Trials / Completed
CompletedNCT03852342
Reactive Doses and Times During Oral Food Challenge to Peanut
Reactive Doses and Times During Oral Food Challenge (OFC) to Peanut
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 262 (actual)
- Sponsor
- University Hospital, Montpellier · Academic / Other
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
Peanut allergy is a growing public health problem in developed countries with more and more hospitalizations for anaphylaxis. It has been determined that sensitization to certain peanut proteins such as rAra h 2, is predictive of allergy and could predict the severity of reaction (anaphylaxis) during Oral food challenges (OFC). So far, consensual threshold for cutaneous test and IgE as predictor in the positivity of OFC have not been determined. Identification of reactive doses for OFC and phenotype of patients would help to personalize management of patients subgroups, with an optimal security.
Conditions
Timeline
- Start date
- 2018-10-10
- Primary completion
- 2019-02-28
- Completion
- 2019-03-20
- First posted
- 2019-02-25
- Last updated
- 2019-04-18
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03852342. Inclusion in this directory is not an endorsement.